These CDX2P9.5-G22Cre transgenic mice harbor a nuclear-localized Cre recombinase with 22 guanine nucleotide repeat between initiating methionine (ATG) codon and the remainder of the coding region altering the cre reading frame. Presumably, following a somatic mutation that results in some frameshift mutation(s) in the guanine nucleotide tract in a subset of somatic cells, resultant expression of a functional Cre recombinase is driven by a 9.5 kb human caudal type homeo box 2 (CDX2) promoter/enhancer sequence. These CDX2P9.5-G22Cre transgenic mice may be useful as a somatic mutation reporter strain and/or to generate conditional mutations in colorectal epithelial cells.
Eric R Fearon, University of Michigan Medical School
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Recombinase-expressing) |
Mice hemizygous for the CDX2P9.5-G22Cre transgene are viable and fertile. The 9.5 kb human caudal type homeo box 2 (CDX2) promoter/enhancer sequence is prevented from driving nuclear-localized Cre recombinase expression as a 22 guanine nucleotide repeat tract between initiating methionine (ATG) codon and the remainder of the coding region alters the cre reading frame. Presumably, following a somatic mutation that results in some frameshift mutation(s) in the guanine nucleotide tract in a subset of somatic cells, resultant expression of a functional Cre recombinase is observed predominantly in colonic epithelium during late gestation and in adult tissues. Specifically, mosaic Cre recombinase expression would be observed in epithelium from the distal ileum and cecum, and mainly the proximal and distal colon from the crypt base to the luminal surface. Cre recombinase expression may also be observed in a few caudal-derived cells during early development. When these transgenic mice are bred with mice containing a loxP-flanked sequence of interest, Cre-mediated recombination is expected to result in deletion of the floxed sequences in these tissues of the offspring that reactivate cre expression. These CDX2P9.5-G22Cre transgenic mice may be useful as a somatic mutation reporter strain and/or to generate conditional mutations in colorectal epithelial cells.
The CDX2P9.5-G22Cre transgene was designed with a 9.5 kb promoter fragment from the 5' flanking sequences of human caudal type homeo box 2 (CDX2) gene, a nuclear-localized Cre recombinase gene modified with a 22 guanine nucleotide repeat tract between its initiating methionine (ATG) codon and the remainder of the Cre-coding region, and a bovine growth hormone polyadenylation cassette. This transgene was injected into (C57BL/6J x SJL/J) hybrid cells. Transgenic founders (line 189) were found to have approximately 80 copies of the transgene and were bred to C57BL/6J mice. The donating investigator reports that this strain was maintained by breeding hemizygous mice with C57BL/6J inbred mice for 7 generations prior to arrival at The Jackson Laboratory. Upon arrival, CDX2P9.5-G22Cre transgenic mice were bred to C57BL/6J inbred mice (Stock No. 000664) for at least one generation to establish the colony. The Y chromosome may not have been fixed to the C57BL/6 genetic background.
Expressed Gene | cre, cre recombinase, bacteriophage P1 |
---|---|
Site of Expression | mosaic Cre recombinase expression is observed in epithelium from the distal ileum and cecum, and mainly the proximal and distal colon from the crypt base to the luminal surface. Cre recombinase expression may also be observed in a few caudal-derived cells during early development. |
Allele Name | transgene insertion 189, Eric R Fearon |
---|---|
Allele Type | Transgenic (Recombinase-expressing) |
Allele Synonym(s) | CDX2P9.5-G22Cre |
Gene Symbol and Name | Tg(CDX2-cre*)189Erf, transgene insertion 189, Eric R Fearon |
Gene Synonym(s) | |
Promoter | CDX2, caudal type homeobox 2, human |
Expressed Gene | cre, cre recombinase, bacteriophage P1 |
Site of Expression | mosaic Cre recombinase expression is observed in epithelium from the distal ileum and cecum, and mainly the proximal and distal colon from the crypt base to the luminal surface. Cre recombinase expression may also be observed in a few caudal-derived cells during early development. |
Strain of Origin | (C57BL/6J x SJL/J) |
Chromosome | UN |
Molecular Note | The CDX2P9.5-G22Cre transgene was designed with a 9.5 kb promoter fragment from the 5' flanking sequences of human caudal type homeo box 2 (CDX2) gene, a nuclear-localized Cre recombinase gene modified with a 22 guanine nucleotide repeat tract between its initiating methionine (ATG) codon and the remainder of the Cre-coding region, and a bovine growth hormone polyadenylation cassette. This transgene was injected into (C57BL/6J x SJL/J) hybrid cells. Transgenic founders (line 189) were found to have approximately 80 copies of the transgene and were bred to C57BL/6J mice. |
Mutations Made By | Eric Fearon, University of Michigan Medical School |
When maintaining a live colony, hemizygotes may be bred with noncarrier (wildtype) siblings or C57BL/6J inbred mice.
When using the B6.Cg-Tg(CDX2-cre*)189Erf/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #009352 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or non carrier for Tg(CDX2-cre*)189Erf |
Frozen Mouse Embryo | B6.Cg-Tg(CDX2-cre*)189Erf/J | $2595.00 |
Frozen Mouse Embryo | B6.Cg-Tg(CDX2-cre*)189Erf/J | $2595.00 |
Frozen Mouse Embryo | B6.Cg-Tg(CDX2-cre*)189Erf/J | $3373.50 |
Frozen Mouse Embryo | B6.Cg-Tg(CDX2-cre*)189Erf/J | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.